Conference Coverage

10-year DCIS recurrence risk dwindles with age


 

References

“We don’t automatically recommend mastectomy under 40, but I think this data does make us very concerned about recurrence, and particularly invasive recurrence and its potential influence then on distant disease,” she said.

The study funding source was not reported. The authors reported having no disclosures. Dr. Tranakas reported no disclosures.

Pages

Recommended Reading

VIDEO: Dr. Ann Partridge discusses counseling young breast cancer patients
MDedge ObGyn
Dose-dense chemotherapy boosts premenopausal breast cancer survival
MDedge ObGyn
VIDEO: Advice varies for chemoprevention, genetic testing in invasive breast cancer
MDedge ObGyn
VIDEO: Breast cancer surgery choice depends on the individual
MDedge ObGyn
VIDEO: Counseling patients considering contralateral prophylactic mastectomy
MDedge ObGyn
VIDEO: Carefully consider impact of MRI to detect contralateral breast cancer
MDedge ObGyn
VIDEO: Weighing the cost-effectiveness of contralateral risk-reducing mastectomy
MDedge ObGyn
VIDEO: Treat most older women with stage I breast cancer with lumpectomy only
MDedge ObGyn
Exploratory analysis provides support for Recurrence Score
MDedge ObGyn
Breast density pegged as risk factor for contralateral cancer
MDedge ObGyn